The pharmaceutical industry is undergoing a rapid technological transformation. This shift has been driven by the need for improved patient experience, increased data quality, and the ability to carry out clinical trials on a global scale. This transformation aims to bring new medicines to market faster than ever before.
However, it’s important to note that even though technology is changing rapidly within this industry, biopharma companies aren’t just adopting technology to be modern or innovative – they are doing so because it will save them money while improving efficiencies at every stage of development from initial concept through post-approval commercialization.
Table of Contents
The pharmaceutical industry as a whole is undergoing a rapid technological transformation
The pharmaceutical industry as a whole is undergoing a rapid technological transformation. The shift to electronic data capture (EDC) has been driven by the need for improved patient experience, increased data quality and the ability to carry out clinical trials on a global scale.
A mix of traditional paper-based systems with automated tools such as web forms and tablet devices characterizes the current state of EDC in biopharma. While these solutions are sufficient for small studies and single sites, they lack scalability for large multi-site studies or global networks of research sites.
Biopharma companies are making the transition from paper-based clinical trials to online trials
Biopharma companies are making the transition from paper-based clinical trials to online trials. This is where e-COA solutions play a significant role in the biopharma industry. Patients’ use of eCOA tools can help them get more involved in their care and provide feedback on the effectiveness of the treatment they receive.
eCOA for biopharma companies gathers data, monitors patient adherence, collect information from physicians and conducts various other activities related to clinical trials effectively without human intervention or oversight, which results in better efficiency and cost savings for both parties involved.
“Medable’s technology adds on your research workflows, scaling to your trials’ needs.”
This shift has been driven by the need for improved patient experience, increased data quality, and the ability to carry out clinical trials on a global scale
The shift to eCoA has been driven by a growing need for improved patient experience, increased data quality and the ability to carry out clinical trials on a global scale.
eCOA tools have significant benefits over paper-based tools
eCOA tools are more efficient, more secure, and scalable to meet the needs of large-scale biopharma companies. They also provide a higher level of accuracy with less cost than paper-based systems.
In addition to being more efficient and accurate than paper-based tools, eCOA tools are also equipped with built-in audit trails that regulatory agencies can use if they choose to examine a company’s processes.
eCOA tools are used by patients to report information and follow up with their physicians regarding their health
eCOA tools are used by patients to report information and follow up with their physicians regarding their health. Physicians then use this data to track patient data and manage the clinical trial process.
While the move to eCOA tools is still in its early stages, there’s no doubt that they have significant benefits over paper-based tools. They provide better data quality, improve patient experience and allow physicians to connect with their patients in new ways. As the biopharma industry undergoes its rapid technological transformation into online trials, it will be important for pharmaceutical companies to stay ahead of their competition by adopting these technologies early on.
